Heart Failure
L1 subspecialty spine topic for Heart Failure (seeded from backend/data/cardiology_taxonomy.yaml).
Also called HF, HFrEF, HFpEF, CHF, congestive heart failure
Sources: 11 new papers · 5 key papers · updated Oct 20, 2026
Unverified · drafted by AI from the sources cited below
Congestive heart failure is the inability of the heart to pump sufficient blood to meet the needs of tissues for oxygen and nutrients.1
Clinically, volume status is typically assessed using a combination of physical examination findings, laboratory values, imaging studies, and invasive procedures.1 Point-of-care ultrasound can be used to determine volume status in patients with congestive heart failure and has the potential to improve the accuracy of volume assessments with little additional cost to the patient.1 Cardiopulmonary exercise testing provides a dynamic, integrated assessment of the respiratory, cardiovascular, and peripheral muscle systems during incremental exercise, enabling quantitative characterization of the pathophysiological mechanisms underlying exercise limitation.2
Diuretics play a significant role in the management of patients with congestive heart failure.1 They are used to relieve the congestive symptoms of heart failure.1 However, appropriate use remains challenging due to complications like electrolyte abnormalities, worsening renal function, and diuretic resistance.1 The major cause of diuretic resistance appears to be localized within the distal tubule.2 Recently introduced sodium-glucose transporter 2 inhibitors and combining different classes of diuretics are therapeutic strategies.2 Additionally, self-care is associated with prevention or early detection of health problems and better overall health-related quality of life.3 Exercise, income, comorbidities, and times of congestive heart failure-related hospitalizations are independent risk factors for frailty, while surgical treatment, comorbidities, and income are independent risk factors for self-care.4
Society guidelines, scientific statements and expert consensus on Heart Failure from the last three months.
These guidelines refine the heart failure classification by LVEF and introduce a stage‑based framework to strengthen prevention, early detection, and timely intervention. They propose a revised nomenclature for therapies.
FDA approvals, label changes, device decisions and recalls on Heart Failure from the last three months.
Manufacturer: Micro Labs Limited. Submission type: SUPPL. Route: ORAL. Form: TABLET, EXTENDED RELEASE
Manufacturer: AUROBINDO PHARMA LTD. Submission type: ORIG. Route: ORAL. Form: CAPSULE
CPET Characteristics in HFrEF, HFpEF and COPD
Journal of Clinical Medicine — Zhou Y — Jul 2026
Point-of-care ultrasound to evaluate volume status in congestive heart failure
Journal of Cardiovascular Imaging — Shaul N — Jul 2026
EXPRESS: Reversible Congestive Heart Failure Associated With Diabetes Mellitus in Two Cats
Journal of Feline Medicine and Surgery Open Reports — Cho J — Apr 2026
Profiling the Swallowing Safety and Efficiency of Patients Presenting With Congestive Heart Failure
Laryngoscope Investigative Otolaryngology — Smaoui S — Apr 2026
Relationship Between Depression, Anxiety Levels, and Coping Mechanisms in Patients with Congestive Heart Failure
Genius Journal — Afrida Y — Oct 2025
The Relationship Between Knowledge Level and Illness Perception in Patients with Congestive Heart Failure
Proceedings Series on Health & Medical Sciences — Liputo G — Oct 2025
Disparities in Diagnostic Utilization Patterns Between Heart Failure With Preserved Ejection Fraction (HFpEF) and Heart Failure With Reduced Ejection Fraction (HFrEF): A Nationwide Analysis
Cureus — Estes-Schmalzl K — Aug 2025
Analysis of Factors Contributing to Readmission in Congestive Heart Failure Patients at Kota Kendari Hospital
Journal of Innovative and Creativity (Joecy) — Aso O — Jul 2025
Diuretic therapy in congestive heart failure
Acta cardiologica. Supplementum — Kennelly P
38 citations · 2021 · among the most cited on Heart Failure
Renal Mechanisms of Diuretic Resistance in Congestive Heart Failure
Kidney and Dialysis — Lameire N
22 citations · 2023 · among the most cited on Heart Failure
Plasma homocysteine levels and risk of congestive heart failure or cardiomyopathy: A Mendelian randomization study
Frontiers in Cardiovascular Medicine — Wang X
20 citations · 2023 · among the most cited on Heart Failure
Frailty Affects Self-Care Behavior in Congestive Heart Failure
Clinical Nursing Research — Jing L
19 citations · 2022 · among the most cited on Heart Failure
Self Care of Heart Failure and Health Related Quality of Life among Congestive Heart Failure Patients in Punjab, India
International Journal of Health Sciences and Research — Patidar A
10 citations · 2021 · among the most cited on Heart Failure
A clinical question appears here only when its condition matches this topic, an outcome and a comparator were extracted from the studies, at least two studies and a patient count are on file, and the certainty is low or higher.
Supports benefit, no benefit shown, and mixed describe the direction of the measured effect. No benefit shown means the evidence does not support a benefit. It is not a finding of harm. Too little evidence means the question did not clear that bar.
Study count, RCT count, and patient count are separate. The patient total adds only studies that are linked into a study family and whose sample size is not flagged as implausible. A reversal is listed only when at least one randomized trial sits on each side of the change.
The overview is drafted from the guideline recommendations, trials, papers, and questions on this page, and every sentence has to cite one of them. It stays unverified until an NPI-verified clinician or a Synapse admin approves it. Approving records that person's name.